Your browser doesn't support javascript.
loading
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma.
Suarez-Kelly, Lorena P; Levine, Kala M; Olencki, Thomas E; Del Campo, Sara E Martin; Streacker, Elizabeth A; Brooks, Taylor R; Karpa, Volodymyr I; Markowitz, Joseph; Bingman, Anissa K; Geyer, Susan M; Kendra, Kari L; Carson, William E.
Afiliação
  • Suarez-Kelly LP; Comprehensive Cancer Center, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, N924 Doan Hall 410 W. 10th Ave, Columbus, OH, 43210-1228, USA.
  • Levine KM; Comprehensive Cancer Center, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, N924 Doan Hall 410 W. 10th Ave, Columbus, OH, 43210-1228, USA.
  • Olencki TE; Medical Oncology, Department of Internal Medicine, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Del Campo SEM; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Streacker EA; Promedica Toledo Hospital, Toledo, OH, USA.
  • Brooks TR; Division of Rheumatology and Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Karpa VI; Comprehensive Cancer Center, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, N924 Doan Hall 410 W. 10th Ave, Columbus, OH, 43210-1228, USA.
  • Markowitz J; Comprehensive Cancer Center, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, N924 Doan Hall 410 W. 10th Ave, Columbus, OH, 43210-1228, USA.
  • Bingman AK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Geyer SM; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
  • Kendra KL; Hematology, Department of Internal Medicine, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH, USA.
  • Carson WE; Department of Biomedical Informatics, The Ohio State University College of Medicine, Columbus, OH, USA.
Cancer Immunol Immunother ; 68(4): 619-629, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30725205
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Leucócitos Mononucleares / Interferon-alfa / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Leucócitos Mononucleares / Interferon-alfa / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Ano de publicação: 2019 Tipo de documento: Article